Incyte Corporation Price Today
Incyte Corporation
INCY
Healthcare
$12.36B
💰
Market Cap
20.8
💸
Price to Earnings
$2.6
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
7 |
Strong Buy |
9 |
Hold |
12 |
Sell |
0 |
Strong Sell |
0 |
INCY Price Forecast Target
55.0 👉 92.0 +67%
INCY EPS Forecast
2.6 👉 5.4 +105%
Financials
Profit Margin
16 %
Revenue Growth
9.3 %
Dividend
$ 0
Held Percent
1.6% - Insiders
100.2% - Institutions
-1.8% - Public
Major Fund Holders
-
💰 $
-
💰 $
-
💰 $
-
💰 $
-
💰 $
Stock Ideas
Ken Fisher Portfolio
Ken Fisher is a prominent American investment analyst, author, and the founder of Fisher Investments, a global investment firm managing billions of dollars in assets for individual and institutional clients. As a highly successful investor and fina…
Israel Englander Portfolio
Israel Englander, a notable figure in the finance industry, began his journey by obtaining his undergraduate degree from NYU before venturing into trading on the American Stock Exchange (AMEX), where he found early success. In 1989, he went on to es…
Larry Robbins Portfolio
Larry Robbins is a successful hedge fund manager who founded Glenview Capital in 2001 after working as a trader at Omega Advisors. His portfolio strategy has led to impressive returns, with Glenview Capital returning 301% after fees and expenses bet…
Bill Gates Portfolio
With a portfolio valued at over $18 billion, the Bill & Melinda Gates Foundation Trust holds the endowment and funds the Bill & Melinda Gates Foundation. Bill and Melinda are the trustees for the Foundation Trust, and the endowment is managed by a t…📮FAQ
Some Frequently Asked Questions.
The Incyte Corporation industry is Biotechnology
The Incyte Corporation sector is Healthcare
The Incyte Corporation forecasted predicted Price to Earnings PE ratio is 10.2
The Incyte Corporation Price to Earnings PE ratio is 20.8
The Market Capitalization of Incyte Corporation is $12.36B
There are total of 186978624 float shares with 100.2% held by Institutions and 1.6% held by insiders
The MIncyte Corporation forecasted Earnings per Share EPS is $5.4
The Incyte Corporation Earnings per Share EPS is 2.6
The Incyte Corporation company has $0 gross profits with 16 profit margins
The Incyte Corporation Earnings Growth is 6.324% with 6.065% quarterly earnings growth
The Incyte Corporation Revenue is $3695649024 with 0.093 revenue growth
The price target for Incyte Corporation stock is $92.0 for the high target and $61.0 for the low target
The consensus analyst recommendations for Incyte Corporation is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Incyte Corporation is Buy, with the following breakdown:
- Buy: 7
- Strong Buy: 9
- Hold: 12
- Sell: 0
- Strong Sell: 0
The Beta of Incyte Corporation is 0.7
The dividend of Incyte Corporation is $0
The dividend yield of Incyte Corporation is 0%
The biggest institutional and mutual fund holders of Incyte Corporation stock are
The Incyte Corporation ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0